These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 14642058)
1. Effect of decoy-oligodeoxynucleotides on expression of inflammation mediators in pMPhi cells from rats. Guo H; Liang HP; Lu FL; Xu X; An B; Hao TZ; Wang FL; Yang WJ Chin J Traumatol; 2003 Dec; 6(6):363-9. PubMed ID: 14642058 [TBL] [Abstract][Full Text] [Related]
2. [The inhibitory effects of dumb-bell decoy oligodeoxynucleotides targeting NF-kappaB on the growth of multiple myeloma cells and IL-6 expression]. Jiang HL; Xue WJ; Liu H; Chen W Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):47-50. PubMed ID: 16388744 [TBL] [Abstract][Full Text] [Related]
3. Transcription factor decoy for nuclear factor-kappaB inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells. Tomita N; Morishita R; Tomita S; Yamamoto K; Aoki M; Matsushita H; Hayashi S; Higaki J; Ogihara T J Hypertens; 1998 Jul; 16(7):993-1000. PubMed ID: 9794740 [TBL] [Abstract][Full Text] [Related]
4. Suppression of nuclear factor-kappaB activity in Kupffer cells protects rat liver graft from ischemia-reperfusion injury. Li JD; Peng Y; Peng XY; Li QL; Li Q Transplant Proc; 2010 Jun; 42(5):1582-6. PubMed ID: 20620478 [TBL] [Abstract][Full Text] [Related]
5. Regression of intracranial aneurysms by simultaneous inhibition of nuclear factor-κB and Ets with chimeric decoy oligodeoxynucleotide treatment. Aoki T; Kataoka H; Nishimura M; Ishibashi R; Morishita R; Miyamoto S Neurosurgery; 2012 Jun; 70(6):1534-43; discussion 1543. PubMed ID: 22186838 [TBL] [Abstract][Full Text] [Related]
6. New treatment of periodontal diseases by using NF-kappaB decoy oligodeoxynucleotides via prevention of bone resorption and promotion of wound healing. Shimizu H; Nakagami H; Morita S; Tsukamoto I; Osako MK; Nakagami F; Shimosato T; Minobe N; Morishita R Antioxid Redox Signal; 2009 Sep; 11(9):2065-75. PubMed ID: 19186992 [TBL] [Abstract][Full Text] [Related]
7. Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides. Fichtner-Feigl S; Fuss IJ; Preiss JC; Strober W; Kitani A J Clin Invest; 2005 Nov; 115(11):3057-71. PubMed ID: 16239967 [TBL] [Abstract][Full Text] [Related]
8. [An experimental study of inhibiting effect of decoy oligodeoxynucleotides on the gene expression of collagen in NIH3T3 cell]. Hao TZ; Liang HP; Lv FL; Xu X; Guo H; Wang FL; Yang WJ; Luo Y; Li L Zhonghua Shao Shang Za Zhi; 2003 Jun; 19(3):175-8. PubMed ID: 12921625 [TBL] [Abstract][Full Text] [Related]
9. [Effect of nuclear factor-kappa B decoy oligodeoxynucleotides on IL-10, IL-13 and nuclear factor-kappa B protein expressions in rabbits with severe lung contusion]. Fang DQ; Yu T; Wan L Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2284-7. PubMed ID: 20965826 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of NF-kappaB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy. Kim KH; Lee ES; Cha SH; Park JH; Park JS; Chang YC; Park KK Exp Mol Pathol; 2009 Apr; 86(2):114-20. PubMed ID: 19118545 [TBL] [Abstract][Full Text] [Related]
11. Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa. Gambari R; Borgatti M; Bezzerri V; Nicolis E; Lampronti I; Dechecchi MC; Mancini I; Tamanini A; Cabrini G Biochem Pharmacol; 2010 Dec; 80(12):1887-94. PubMed ID: 20615393 [TBL] [Abstract][Full Text] [Related]
12. Ex vivo transfer of nuclear factor-kappaB decoy ameliorates hepatic cold ischemia/reperfusion injury. Yoshizumi T; Ikeda Y; Kaneda Y; Sueishi K Transplant Proc; 2009 Jun; 41(5):1504-7. PubMed ID: 19545666 [TBL] [Abstract][Full Text] [Related]
13. Augmented regeneration of partial liver allograft induced by nuclear factor-kappaB decoy oligodeoxynucleotides-modified dendritic cells. Xu MQ; Suo YP; Gong JP; Zhang MM; Yan LN World J Gastroenterol; 2004 Feb; 10(4):573-8. PubMed ID: 14966919 [TBL] [Abstract][Full Text] [Related]
14. A role for NF-kappaB-dependent gene transactivation in sunburn. Abeyama K; Eng W; Jester JV; Vink AA; Edelbaum D; Cockerell CJ; Bergstresser PR; Takashima A J Clin Invest; 2000 Jun; 105(12):1751-9. PubMed ID: 10862790 [TBL] [Abstract][Full Text] [Related]
15. [Effects of nuclear factor-kappaB decoy oligodeoxynucleotide on the function of human umbilical artery smooth muscle cells induced by umbilical sera in preeclampsia]. Jiang RZ; Huang YJ; Gu JH; Mu WH; Chen HP Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):87-91. PubMed ID: 17442180 [TBL] [Abstract][Full Text] [Related]
16. [The effects of nuclear factor kappa B decoy oligodeoxynucleotides on ciglitazone-induced differentiation of lung cancer cells A549]. Zhang HL; Zhang ZX; Xu YJ Zhonghua Nei Ke Za Zhi; 2004 Mar; 43(3):201-4. PubMed ID: 15059376 [TBL] [Abstract][Full Text] [Related]
18. Effect of NF-κB decoy oligodeoxynucleotide on LPS/high-fat diet-induced atherosclerosis in an animal model. Kim SJ; Park JH; Kim KH; Lee WR; Lee S; Kwon OC; Kim KS; Park KK Basic Clin Pharmacol Toxicol; 2010 Dec; 107(6):925-30. PubMed ID: 20649557 [TBL] [Abstract][Full Text] [Related]
19. Immunomodulation of cystic fibrosis epithelial cells via NF-κB decoy oligonucleotide-coated polysaccharide nanoparticles. Wardwell PR; Bader RA J Biomed Mater Res A; 2015 May; 103(5):1622-31. PubMed ID: 25087735 [TBL] [Abstract][Full Text] [Related]
20. Beta-endorphin ameliorates synovial cell hyperfunction in the collagen-induced arthritis rat model by specific downregulation of NF-kappa B activity. Yin H; Zhang F; Yu M; Cheng H; Lin J; Gao Y; Han B; Zhu L Neuroendocrinology; 2005; 81(1):10-8. PubMed ID: 15802927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]